BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  UroGen Pharma to Host Third Quarter 2017 Financial Results Conference Call on Tuesday, November 14, 2017

  The Company’s third quarter 2017 financial results will be released prior to the call.

  November 8, 2017

   · 

  1 min read
• Policy

  Fortress Biotech Announces Cellvation’s CEVA101 Granted FDA Regenerative Medicine Advanced Therapy Designation for the Treatment of Traumatic Brain Injury

  CEVA101 is being developed in partnership with The University of Texas Health Science Center at Houston.

  November 8, 2017

   · 

  7 min read
• Business

  G1 Therapeutics Reports Third Quarter 2017 Financial Results and Recent Operational Highlights

  Operating expenses were $15.9 million for the third quarter of 2017, compared to $6.6 million for the third quarter of 2016.

  November 8, 2017

   · 

  7 min read
• Drug Development

  Immunovaccine Announces Regulatory Clearance for Phase II Clinical Trial Evaluating DPX-Survivac in Combination With Merck’s Checkpoint Inhibitor Pembrolizumab in DLBCL

  This trial is designed to evaluate the safety and efficacy of Immunovaccine’s lead candidate along with Merck’s pembrolizumab and low-dose cyclophosphamide in this patient population.

  November 8, 2017

   · 

  5 min read
• Business

  TG Therapeutics Provides Business Update and Reports Third Quarter 2017 Financial Results

  Cash, cash equivalents, investment securities, and interest receivable were $91.8 million as of September 30, 2017, as compared to $86.5 million at June 30, 2017.

  November 8, 2017

   · 

  9 min read
• Business

  Tyme Provides Clinical and Corporate Update for the Fiscal First Half 2017

  Investor conference call scheduled for 10 am ET today.

  November 8, 2017

   · 

  8 min read
• Business

  The Science Center Release: These Three Startups are Simplifying and Streamlining Healthcare

  Three companies aiming to simplify and streamline healthcare fields have set up shop at the The Science Center’s Port business incubator. ChromaTan, InnaMed and Group K Diagnostics are all occupying lab space at 3624 Market Street.

  November 8, 2017

   · 

  2 min read
• Business

  Axsome Therapeutics Reports Third Quarter 2017 Financial Results

  As of September 30, 2017, Axsome had $31.7 million of cash compared to $36.6 million of cash as of December 31, 2016.

  November 8, 2017

   · 

  10 min read
• Business

  Ginolis Announces Distribution Agreement With Darwin Microfluidics for Dispensing Pumps

  The distribution agreement represents a major step for Ginolis in making its’ patented dispensing technology available to researchers and scientists around the world.

  November 8, 2017

   · 

  2 min read
• Business

  G1 Therapeutics Makes Key Executive Appointments

  The company appointed Barclay (Buck) Phillips as CFO and Sr. VP, Corporate Development, and Chandra Lovejoy as VP, Global Regulatory Affairs.

  November 8, 2017

   · 

  5 min read